Can a tight closure after hernia repair cause pulmonary arterial hypertension (PAH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Tight Hernia Repair Closure Cause Pulmonary Arterial Hypertension (PAH)?

No, tight closure after hernia repair does not cause pulmonary arterial hypertension (PAH) as a disease entity, but it can cause acute respiratory complications through increased intra-abdominal pressure that affects pulmonary mechanics—this is a completely different pathophysiologic process that resolves when the pressure normalizes.

Understanding the Distinction

You're asking about two fundamentally different conditions:

  • PAH is a chronic, progressive disease of the pulmonary vasculature involving endothelial dysfunction, smooth muscle proliferation, and remodeling of pulmonary arteries 1, 2. It develops from genetic factors, connective tissue diseases, congenital heart disease, or other systemic conditions—not from mechanical abdominal pressure.

  • Acute respiratory dysfunction from increased intra-abdominal pressure is what actually occurs after tight hernia closure. This is a mechanical problem, not vascular remodeling.

What Actually Happens After Tight Hernia Closure

Immediate Postoperative Changes

When surgeons close a hernia "too tightly" (particularly in complex ventral hernias with loss of domain), the following occurs:

  • Intra-abdominal pressure (IAP) increases significantly from baseline (median 5 mmHg) to elevated levels (median 9 mmHg) immediately postoperatively 3
  • Pulmonary plateau pressure rises from 11 to 12 mmHg on average 3
  • Intra-abdominal hypertension (IAH) develops in 92% of complex hernia repairs, with IAP ≥12 mmHg 4
  • Abdominal compartment syndrome (ACS) occurs in 16% when IAP exceeds 20 mmHg with new organ dysfunction 4

The Critical Finding: This Resolves Quickly

The key clinical point is that these pressure changes are transient and typically resolve by postoperative day 1 4. Measurements show:

  • Preoperative IAP: 12.7 ± 4.0 mmHg
  • Immediate postoperative: 18.2 ± 5.4 mmHg
  • Postoperative day 1: 12.9 ± 5.2 mmHg 4

This temporal pattern is completely inconsistent with PAH, which is a chronic progressive disease requiring months to years to develop.

Risk Factors for Respiratory Complications (Not PAH)

Hernia Volume Matters

Hernia volume >20% of abdominal cavity predicts postoperative respiratory events 5, 4. Specifically:

  • Patients with large hernias who have pulmonary plateau pressure increases ≥6 mmHg are more likely to have postoperative respiratory complications 4
  • These patients may require remaining intubated postoperatively, but plateau pressures improve by day 1 (from 27.4 ± 4.0 mmHg postop to 20.1 ± 3.7 mmHg on day 1) 4
  • Higher BMI is associated with greater increases in pulmonary plateau pressure 3

The Neonatal Exception

The only documented cases linking tight abdominal closure to actual pulmonary hypertension involve neonates with omphalocele 6. Two infants developed postoperative PH after primary closure of small omphaloceles, with one death from refractory PH 6. However, this represents:

  1. A completely different patient population (neonates vs. adults)
  2. Different underlying pathophysiology (developmental lung issues, low Apgar scores)
  3. A congenital defect repair, not acquired hernia

This is not applicable to adult hernia surgery.

Clinical Management Algorithm

Intraoperative Monitoring

For complex hernia repairs, surgeons should:

  1. Measure bladder pressure intraoperatively as an objective guide for closure tension 7
  2. Consider delayed abdominal closure (DAC) if IAP >20 mmHg after visceral reduction 8, 7
  3. Monitor pulmonary plateau pressure changes ≥6 mmHg as a predictor of respiratory complications 4

Postoperative Management

When IAH develops (IAP ≥12 mmHg) 8:

  1. Monitor IAP with serial measurements at least every 4-6 hours while critically ill 8
  2. If IAP >20 mmHg with new organ failure, this defines ACS and requires intervention 8
  3. Medical management options include: sedation/analgesia, neuromuscular blockade, gastric decompression, prokinetic agents, and judicious fluid management 8
  4. Surgical decompression is reserved for refractory cases with persistent IAP >20 mmHg and organ dysfunction 8

The "Permissible" Concept

Elevated IAP following elective hernia repair is common, transient, and should be considered "permissible" in this specific context 4. The key is distinguishing between:

  • Expected postoperative IAH that resolves within 24-48 hours
  • True ACS requiring intervention (IAP >20 mmHg with organ dysfunction)

Common Pitfalls to Avoid

  1. Don't confuse acute respiratory dysfunction with PAH—they are completely different diseases with different treatments
  2. Don't panic about IAH in the immediate postoperative period—it's expected and usually resolves by day 1
  3. Don't ignore objective measurements—use bladder pressure monitoring rather than subjective assessment of abdominal tension
  4. Don't delay intervention for true ACS—IAP >20 mmHg with organ dysfunction requires action per guidelines 8

Bottom Line

If someone had hernia surgery and is experiencing breathing problems, this is due to increased abdominal pressure affecting lung mechanics, not pulmonary arterial hypertension. The treatment approaches are completely different: managing IAH involves pressure monitoring and potentially surgical decompression 8, while PAH requires vasodilators and pulmonary-specific therapies 1, 2. The respiratory issues from tight hernia closure typically resolve within 24-48 hours 4, 9, whereas PAH is a chronic progressive disease.

References

Research

Pulmonary arterial hypertension: Focused therapeutic update.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.